With regularity approval (ABS) behind as now, I would of thought...

With regularity approval (ABS) behind as now, I would of thought the share price would have slowly been moving up, this is like a biotech company getting FDA approval for their products, shows how much I know I guess. But with the recent CR very well supported at 15 cents by some high flyers, would have given investors more confidence in the future ahead for GEV. So I sit here scratching my head, I go back to the start and why I invested in the first place, and the more I go over the business plan, and all GEVs announcements, and all the fingers in the pie they have the investment looks more compelling every time I go back and check all the information available. Maybe I’m missing something here, I don’t know, but with the resent 15 cents CR, these investors would be thinking of a very high return on that. IMO even if only half of what GEV are looking at comes off, they will have a market cap many times higher than what we have now. 
So I couldn’t help myself again today and went with what I think and have researched, and bought more GEV at a bargain price. Time will tell I guess if it is a bargain at these levels or not.
as always GLTAH